PK MED

PK MED is a pioneering French biotech company, privately owned and founded in 2019 in Lyon, France, with the backing of Truffle Capital, a leading European venture capital firm specializing in life sciences. Built around a dedicated team of passionate and seasoned experts in pharmaceutical sciences, drug delivery, and biomaterials design, PK MED combines innovation and expertise to develop cutting-edge solutions in healthcare. PK MED specializes in the development of innovative, custom-designed, injectable, and biodegradable micro-implants, leveraging its expertise to address critical healthcare challenges. Our focus lies in advanced drug delivery systems for rheumatology and pioneering cell-homing techniques to enhance the success of bone marrow transplantation. Driven by a commitment to unmet medical needs, PK MED has built a promising portfolio of early-stage projects targeting key therapeutic areas, including gout flares, osteoarthritis, and hemoglobinopathies